STERIS Stock (NYSE:STE)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$214.07

52W Range

$195.14 - $269.44

50D Avg

$211.97

200D Avg

$234.68

Market Cap

$21.28B

Avg Vol (3M)

$816.18K

Beta

0.92

Div Yield

$2.52 (1.15%)

STE Company Profile


STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Show More

Industry

Medical - Specialties

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

IE

Employees

17,937

IPO Date

Jun 01, 1992

Website

STE Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 26Mar 25Mar 24
Product$3.06B$2.87B$2.76B
Service$2.88B$2.59B$2.37B

Fiscal year ends in Mar 26 | Currency in USD

STE Financial Summary


Mar 26Mar 25Mar 24
Revenue$5.94B$5.46B$5.14B
Operating Income$1.10B$866.64M$836.12M
Net Income$785.10M$614.64M$378.24M
EBITDA$1.10B$1.36B$1.41B
Basic EPS$7.93$6.24$3.83
Diluted EPS$7.93$6.20$3.81

Fiscal year ends in Mar 26 | Currency in USD

Latest Earnings Call Transcripts


Q4 26May 12, 26 | 12:00 AM
Q3 26Feb 05, 26 | 9:00 AM
Q2 26Nov 06, 25 | 9:00 AM

Peer Comparison


TickerCompany
WATWaters Corporation
BIIBBiogen Inc.
SNNSmith & Nephew plc
PHGKoninklijke Philips N.V.
ZBHZimmer Biomet Holdings, Inc.
WSTWest Pharmaceutical Services, Inc.
DGXQuest Diagnostics Incorporated
PODDInsulet Corp.
LHLabcorp Holdings Inc.
DXCMDexCom, Inc.